Osteo-F, a Newly Developed Herbal Formula, Ameliorates Osteoarthritis Through the NF-κB/IκB/JNK Pathway Based on...

Area of Science:

• Integrative Medicine
• Pharmacology
• Biochemistry

Background:

• Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation, pain, and reduced mobility.
• Current OA treatments have limitations and potential side effects, necessitating novel therapeutic approaches.
• Herbal ingredients like *Schizandra chinensis*, *Lycium chinense*, and *Eucommia ulmoides* possess traditional health benefits.

Purpose of the Study:

• To investigate Osteo-F, a novel herbal formulation, as a potential functional ingredient for osteoarthritis management.
• To elucidate the molecular mechanisms underlying Osteo-F's effects on inflammation and cartilage preservation in OA.

Main Methods:

• Network pharmacology analysis to identify key pathways and targets of Osteo-F.
• In vivo studies using a monosodium iodoacetate-induced OA rat model to assess efficacy.
• In vitro assays to evaluate the impact of Osteo-F on inflammatory signaling pathways (JNK, NF-κB) and matrix metalloproteinases.

Main Results:

• Network pharmacology identified Osteo-F's involvement in the TNF signaling pathway, crucial for OA inflammation.
• In vivo experiments showed Osteo-F significantly improved arthritis scores, bone mineral content, and bone mineral density in OA rats.
• Histological analysis confirmed cartilage preservation, while in vitro studies demonstrated reduced activation of JNK and NF-κB pathways, decreasing inflammatory mediators.

Conclusions:

• Osteo-F exhibits significant anti-inflammatory and cartilage-protective effects in preclinical OA models.
• The formulation modulates key inflammatory pathways (TNF, JNK, NF-κB) and reduces cartilage-degrading enzymes.
• Osteo-F presents potential as a functional food ingredient for supporting joint health in osteoarthritis management, warranting clinical investigation.